Lixte Biotechnology Holdings Inc.(LIXT)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

LIXT Lixte Biotechnology Holdings Inc.

交易中 06-29 12:37:24 EDT

7.79

+0.60

+8.34%

最高7.80	最低7.00	成交量23.46万
今开7.22	昨收7.19	日振幅11.20%
总市值1.35亿	流通市值8,841万	总股本1,739万
成交额175.50万	换手率2.07%	流通股本1,135万
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

数据加载中...

北京优虎网络科技有限公司

{"stockData":{"symbol":"LIXT","market":"US","secType":"STK","nameCN":"Lixte Biotechnology Holdings Inc.","latestPrice":7.79,"timestamp":1782751018140,"preClose":7.19,"halted":0,"volume":234558,"delay":0,"changeRate":0.08344923504867867,"floatShares":11348704,"shares":17386500,"eps":-1.15,"marketStatus":"交易中","change":0.6,"latestTime":"06-29 12:37:24 EDT","open":7.22,"high":7.8,"low":6.995,"amount":1754982.89343,"amplitude":0.111961,"askPrice":7.8,"askSize":10200,"bidPrice":7.73,"bidSize":1,"shortable":3,"etf":0,"ttmEps":-1.15,"tradingStatus":2,"nextMarketStatus":{"tag":"盘后交易","tradingStatus":3,"beginTime":1782763200000},"marketStatusCode":2,"adr":0,"listingDate":1606280400000,"exchange":"NASDAQ","adjPreClose":7.19,"preHourTrading":{"tag":"盘前","latestPrice":7.48,"preClose":7.19,"latestTime":"08:29 EDT","volume":709,"amount":5328.5700424,"timestamp":1782736147345,"change":0.29,"changeRate":0.040334,"amplitude":0.013561},"postHourTrading":{"tag":"盘后","latestPrice":7.13,"preClose":7.19,"latestTime":"18:11 EDT","volume":7175,"amount":51266.7894,"timestamp":1782511893238,"change":-0.06,"changeRate":-0.008345,"amplitude":0.002782},"volumeRatio":1.432149},"requestUrl":"/m/hq/s/LIXT","defaultTab":"news","newsList":[{"id":"1169183823","title":"Lixte Biotechnology Holdings Inc. 更新Nomad收购案进展；交易预计于2026年7月1日左右完成","url":"https://stock-news.laohu8.com/highlight/detail?id=1169183823","media":"美股速递","labels":["corporation","merge"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1169183823?lang=zh_cn&edition=full","pubTime":"2026-06-18 20:33","pubTimestamp":1781786038,"startTime":"0","endTime":"0","summary":"Lixte Biotechnology Holdings Inc. 就其收购Nomad公司的交易提供了最新进展。该笔交易预计将于2026年7月1日或大约该日期完成交割。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation,merge","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LIXT","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2642295210","title":"从抗癌药到电力基础设施：纳指成份股LIXTE Bio跨界转型剑指AI电力市场","url":"https://stock-news.laohu8.com/highlight/detail?id=2642295210","media":"环球市场播报","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2642295210?lang=zh_cn&edition=full","pubTime":"2026-06-12 21:40","pubTimestamp":1781271634,"startTime":"0","endTime":"0","summary":"2026年最引人注目的企业转型之一，正在将一家临床阶段的生物科技公司重塑为电力基础设施企业，目标直指制约AI繁荣的电力短缺问题。　　LIXTE Biotechnology Holdings， Inc．正彻底告别其作为抗癌药物开发商的起源，计划转型为纯粹的电力基础设施公司。根据已签署的最终协议，LIXTE将收购NOMAD Transportable Power Systems， Inc．的全部股权。交易完成后，LIXTE计划更名为NOMAD Power Solutions，定位为“电力可用性平台”。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/usstock/c/2026-06-12/doc-iniceimp2125732.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"sina_us","symbols":["LIXT","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1131591926","title":"Lixte Biotechnology 将收购移动式公用事业级电池储能系统市场领导者 Nomad Transportable Power Systems","url":"https://stock-news.laohu8.com/highlight/detail?id=1131591926","media":"美股速递","labels":["corporation","merge"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1131591926?lang=zh_cn&edition=full","pubTime":"2026-06-12 20:30","pubTimestamp":1781267441,"startTime":"0","endTime":"0","summary":"Lixte Biotechnology Holdings Inc. 宣布，已达成协议收购 Nomad Transportable Power Systems。该公司是移动式、公用事业级电池储能系统（BESS）领域的市场领导者。此次收购旨在整合Lixte在生物技术领域的研发能力与Nomad在先进能源存储解决方案方面的专长，以开拓清洁能源与生物科技交叉领域的新兴市场机会。交易细节，包括具体收购对价及完成时间表，将在后续公告中披露。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation,merge","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","LIXT"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1112843684","title":"Lixte Biotechnology宣布完成按市价注册直接发行，募资1656.6万美元，为下一阶段战略增长强化资产负债表","url":"https://stock-news.laohu8.com/highlight/detail?id=1112843684","media":"美股速递","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1112843684?lang=zh_cn&edition=full","pubTime":"2026-06-03 20:31","pubTimestamp":1780489884,"startTime":"0","endTime":"0","summary":"Lixte Biotechnology Holdings Inc. 宣布，已根据纳斯达克规则完成一项按市价定价的注册直接发行，募集资金总额达16,566,027美元。此举旨在强化公司资产负债表，为其下一阶段的战略增长计划提供资金支持。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LIXT","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1132574968","title":"Lixte Biotechnology Holdings 拟寻求战略收购伙伴，专注推进癌症治疗的制药与医疗技术业务","url":"https://stock-news.laohu8.com/highlight/detail?id=1132574968","media":"美股速递","labels":["corporation","merge"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1132574968?lang=zh_cn&edition=full","pubTime":"2026-06-01 20:51","pubTimestamp":1780318274,"startTime":"0","endTime":"0","summary":"Lixte Biotechnology Holdings Inc. 宣布，将为其专注于推进癌症治疗的制药与医疗技术业务，积极寻求战略收购伙伴。此举旨在通过整合外部资源与专业技术，加速其在肿瘤治疗领域的研发管线进展与业务拓展。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation,merge","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","LIXT"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1132408423","title":"Lixte Biotechnology宣布战略转型，进军AI能源基础设施设备与服务领域；Denham Capital创始人Stuart D. Porter将加入董事会","url":"https://stock-news.laohu8.com/highlight/detail?id=1132408423","media":"美股速递","labels":["corporation"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1132408423?lang=zh_cn&edition=full","pubTime":"2026-06-01 20:50","pubTimestamp":1780318227,"startTime":"0","endTime":"0","summary":"Lixte Biotechnology Holdings Inc. 宣布了一项重大战略转型，公司将业务重心转向人工智能能源基础设施设备与服务领域。与此同时，知名投资机构Denham Capital的创始人Stuart D. Porter已同意加入公司董事会。从专注于生物技术研发，Lixte Biotechnology如今将着力于为快速发展的AI与能源基础设施融合领域提供关键设备与综合服务。公司表示，此次战略重塑是基于对能源行业未来趋势的深度研判，特别是人工智能技术对能源基础设施现代化、智能化改造的推动作用。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","LIXT"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1152039806","title":"Lixte Biotechnology Holdings Inc. 提交2026财年第一季度10-Q表格季报，同步更新业务进展","url":"https://stock-news.laohu8.com/highlight/detail?id=1152039806","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1152039806?lang=zh_cn&edition=full","pubTime":"2026-05-15 05:20","pubTimestamp":1778793647,"startTime":"0","endTime":"0","summary":"Lixte Biotechnology Holdings Inc. 已正式向美国证券交易委员会提交了截至2026年第一季度的10-Q格式季度报告。此次申报不仅涵盖了法定的财务数据，公司还借此机会向市场同步了其最新的业务运营进展。\n报告详细阐述了公司在报告期内的财务状况。与此同时，Lixte Biotechnology 也重点介绍了其在核心研发管线上的推进情况，包括临床前研究及临床试验的阶段性成果，为投资者提供了关于公司发展动态的全面视角。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","LIXT"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1190753577","title":"年度妇科护理学会年会发布卵巢癌研究积极成果","url":"https://stock-news.laohu8.com/highlight/detail?id=1190753577","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1190753577?lang=zh_cn&edition=full","pubTime":"2026-04-13 20:02","pubTimestamp":1776081771,"startTime":"0","endTime":"0","summary":"在近日举行的年度妇科护理学会会议上，一项关于卵巢癌治疗的研究公布了令人鼓舞的临床数据。该研究展示了在提高患者生存率和改善治疗效果方面的显著进展，为卵巢癌治疗领域带来了新的希望。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","LIXT"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2618318602","title":"Lixte Biotechnology Holdings, Inc.盘中异动 早盘股价大涨7.38%","url":"https://stock-news.laohu8.com/highlight/detail?id=2618318602","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2618318602?lang=zh_cn&edition=full","pubTime":"2026-03-09 22:46","pubTimestamp":1773067604,"startTime":"0","endTime":"0","summary":"北京时间2026年03月09日22时46分，Lixte Biotechnology Holdings, Inc.股票出现波动，股价急速上涨7.38%。Lixte Biotechnology Holdings, Inc.股票所在的生物技术行业中，整体跌幅为0.25%。其相关个股中，Xenon制药、An2 Therapeutics, Inc.、Relmada Therapeutics, Inc.涨幅较大，Relmada Therapeutics, Inc.、An2 Therapeutics, Inc.、Edesa Biotech, Inc.较为活跃，换手率分别为39.24%、23.80%、22.76%，振幅较大的相关个股有An2 Therapeutics, Inc.、Moolec Science Sa C/Wts 30/01/2028、Polaryx Therapeutics, Inc.，振幅分别为42.46%、33.71%、29.85%。Lixte Biotechnology Holdings, Inc.公司简介：Lixte Biotechnology Holdings Inc 是一家生物制药公司，致力于通过开发一类名为蛋白磷酸酶2A抑制剂的药物来改善患者的生活。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2026030922464497ab323a&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2026030922464497ab323a&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LIXT","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2610098961","title":"Lixte Biotechnology Holdings, Inc.盘中异动 股价大跌8.92%报2.45美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2610098961","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2610098961?lang=zh_cn&edition=full","pubTime":"2026-02-11 22:55","pubTimestamp":1770821758,"startTime":"0","endTime":"0","summary":"北京时间2026年02月11日22时55分，Lixte Biotechnology Holdings, Inc.股票出现波动，股价快速下挫8.92%。Lixte Biotechnology Holdings, Inc.股票所在的生物技术行业中，整体跌幅为0.92%。其相关个股中，Quince Therapeutics, Inc.、Klotho Neurosciences Inc C/Wts 21/06/2029 、Pmgc Holdings Inc.涨幅较大，Pmgc Holdings Inc.、Quince Therapeutics, Inc.、Aspire Biopharma Holdings, Inc.较为活跃，换手率分别为1955.55%、318.32%、179.98%，振幅较大的相关个股有Quince Therapeutics, Inc.、Tuhura Biosciences, Inc.、Biorestorative Therapies, Inc.，振幅分别为27.25%、23.08%、21.76%。Lixte Biotechnology Holdings, Inc.公司简介：Lixte Biotechnology Holdings Inc 是一家生物制药公司，致力于通过开发一类名为蛋白磷酸酶2A抑制剂的药物来改善患者的生活。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260211225558a4988e76&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260211225558a4988e76&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LIXT","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2604941923","title":"Lixte Biotechnology Holdings, Inc.盘中异动 早盘股价大涨5.58%报3.60美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2604941923","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2604941923?lang=zh_cn&edition=full","pubTime":"2026-01-17 00:27","pubTimestamp":1768580853,"startTime":"0","endTime":"0","summary":"北京时间2026年01月17日00时27分，Lixte Biotechnology Holdings, Inc.股票出现波动，股价急速拉升5.58%。Lixte Biotechnology Holdings, Inc.股票所在的生物技术行业中，整体涨幅为0.17%。Lixte Biotechnology Holdings, Inc.公司简介：Lixte Biotechnology Holdings Inc 是一家生物制药公司，致力于通过开发一类名为蛋白磷酸酶2A抑制剂的药物来改善患者的生活。公司认为，蛋白磷酸酶抑制剂对多种癌症具有治疗潜力。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260117002733a723af1c&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260117002733a723af1c&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LIXT","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2602134595","title":"Lixte Biotechnology Holdings, Inc.盘中异动 股价大跌5.46%报3.73美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2602134595","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2602134595?lang=zh_cn&edition=full","pubTime":"2026-01-09 03:37","pubTimestamp":1767901068,"startTime":"0","endTime":"0","summary":"北京时间2026年01月09日03时37分，Lixte Biotechnology Holdings, Inc.股票出现异动，股价大幅下挫5.46%。Lixte Biotechnology Holdings, Inc.股票所在的生物技术行业中，整体跌幅为2.05%。其相关个股中，Enliven Therapeutics, Inc.、Century Therapeutics, Inc.、Moonlake Immunotherapeutics涨幅较大，Pmgc Holdings Inc.、Acrivon Therapeutics, Inc.、Gri Bio, Inc.较为活跃，换手率分别为523.88%、126.79%、81.10%，振幅较大的相关个股有Abpro Holdings Inc C/Wts 12/11/2029 、Enliven Therapeutics, Inc.、Briacell Therapeutics Corp C/Wts 26/02/2026，振幅分别为146.48%、59.43%、52.53%。Lixte Biotechnology Holdings, Inc.公司简介：Lixte Biotechnology Holdings Inc 是一家生物制药公司，致力于通过开发一类名为蛋白磷酸酶2A抑制剂的药物来改善患者的生活。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260109033748a4ad21a0&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260109033748a4ad21a0&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LIXT","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2517290299","title":"Lixte Biotechnology Holdings  Inc C/Wts 30/11/2025 (To Pur Com)股价重挫59.76% 市值跌1999.75万美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2517290299","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2517290299?lang=zh_cn&edition=full","pubTime":"2025-03-06 04:55","pubTimestamp":1741208101,"startTime":"0","endTime":"0","summary":"北京时间2025年03月06日04时55分，Lixte Biotechnology Holdings  Inc C/Wts 30/11/2025 股票出现异动，股价大幅下挫59.76%。Lixte Biotechnology Holdings  Inc C/Wts 30/11/2025 股票所在的生物技术行业中，整体涨幅为1.97%。Lixte Biotechnology Holdings  Inc C/Wts 30/11/2025 公司简介：Lixte Biotechnology Holdings Inc 是一家生物制药公司，致力于通过开发一种名为蛋白磷酸酶 2A 抑制剂的药物来改善患者的生活。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250306045502a261318b&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250306045502a261318b&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LIXT","BK4139","LIXTW"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2516581652","title":"Lixte Biotechnology Holdings, Inc.盘中异动 下午盘快速跳水5.38%报1.23美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2516581652","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2516581652?lang=zh_cn&edition=full","pubTime":"2025-03-04 02:36","pubTimestamp":1741026978,"startTime":"0","endTime":"0","summary":"北京时间2025年03月04日02时36分，Lixte Biotechnology Holdings, Inc.股票出现波动，股价急速下跌5.38%。Lixte Biotechnology Holdings, Inc.股票所在的生物技术行业中，整体涨幅为0.56%。其相关个股中，Bioxcel Therapeutics, Inc.、Abpro Holdings Inc C/Wts 12/11/2029 、Radiopharm Theranostics Limited涨幅较大，Bioxcel Therapeutics, Inc.、Allarity Therapeutics, Inc.、Entero Therapeutics Inc.较为活跃，换手率分别为4402.35%、195.56%、179.64%，振幅较大的相关个股有Bioxcel Therapeutics, Inc.、Radiopharm Theranostics Limited、Entero Therapeutics Inc.，振幅分别为206.20%、119.50%、70.53%。Lixte Biotechnology Holdings, Inc.公司简介：Lixte Biotechnology Holdings Inc 是一家生物制药公司，致力于通过开发一种名为蛋白磷酸酶 2A 抑制剂的药物来改善患者的生活。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250304023618989a46cf&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250304023618989a46cf&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","LIXT"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2516797233","title":"Lixte Biotechnology Holdings, Inc.盘中异动 大幅跳水5.71%","url":"https://stock-news.laohu8.com/highlight/detail?id=2516797233","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2516797233?lang=zh_cn&edition=full","pubTime":"2025-03-01 00:10","pubTimestamp":1740759032,"startTime":"0","endTime":"0","summary":"北京时间2025年03月01日00时10分，Lixte Biotechnology Holdings, Inc.股票出现波动，股价快速下跌5.71%。Lixte Biotechnology Holdings, Inc.股票所在的生物技术行业中，整体涨幅为0.24%。Lixte Biotechnology Holdings, Inc.公司简介：Lixte Biotechnology Holdings Inc 是一家生物制药公司，致力于通过开发一种名为蛋白磷酸酶 2A 抑制剂的药物来改善患者的生活。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250301001032a2581a7c&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250301001032a2581a7c&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LIXT","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2514389704","title":"Lixte Biotechnology Holdings, Inc.盘中异动 早盘大幅上涨6.67%","url":"https://stock-news.laohu8.com/highlight/detail?id=2514389704","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2514389704?lang=zh_cn&edition=full","pubTime":"2025-02-27 23:25","pubTimestamp":1740669934,"startTime":"0","endTime":"0","summary":"北京时间2025年02月27日23时25分，Lixte Biotechnology Holdings, Inc.股票出现异动，股价大幅拉升6.67%。Lixte Biotechnology Holdings, Inc.股票所在的生物技术行业中，整体涨幅为1.17%。Lixte Biotechnology Holdings, Inc.公司简介：Lixte Biotechnology Holdings Inc 是一家生物制药公司，致力于通过开发一种名为蛋白磷酸酶 2A 抑制剂的药物来改善患者的生活。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025022723253498951be8&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025022723253498951be8&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LIXT","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2514389852","title":"Lixte Biotechnology Holdings  Inc C/Wts 30/11/2025 (To Pur Com)盘中异动 临近收盘大幅下跌20.12%报0.040美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2514389852","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2514389852?lang=zh_cn&edition=full","pubTime":"2025-02-27 05:11","pubTimestamp":1740604261,"startTime":"0","endTime":"0","summary":"北京时间2025年02月27日05时11分，Lixte Biotechnology Holdings  Inc C/Wts 30/11/2025 股票出现异动，股价大幅跳水20.12%。Lixte Biotechnology Holdings  Inc C/Wts 30/11/2025 股票所在的生物技术行业中，整体跌幅为0.66%。Lixte Biotechnology Holdings  Inc C/Wts 30/11/2025 公司简介：Lixte Biotechnology Holdings Inc 是一家生物制药公司，致力于通过开发一种名为蛋白磷酸酶 2A 抑制剂的药物来改善患者的生活。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250227051101a2554f17&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250227051101a2554f17&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LIXTW","BK4139","LIXT"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2514609015","title":"Lixte Biotechnology Holdings, Inc.盘中异动 股价大涨9.69%报1.45美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2514609015","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2514609015?lang=zh_cn&edition=full","pubTime":"2025-02-25 22:32","pubTimestamp":1740493927,"startTime":"0","endTime":"0","summary":"北京时间2025年02月25日22时32分，Lixte Biotechnology Holdings, Inc.股票出现波动，股价急速拉升9.69%。Lixte Biotechnology Holdings, Inc.股票所在的生物技术行业中，整体涨幅为0.15%。其相关个股中，Moleculin Biotech, Inc.、Adial Pharmaceuticals, Inc、Silexion Therapeutics Corp涨幅较大，Gt Biopharma, Inc.、Moleculin Biotech, Inc.、Adial Pharmaceuticals, Inc较为活跃，换手率分别为750.23%、464.65%、229.00%，振幅较大的相关个股有Adial Pharmaceuticals, Inc、Silexion Therapeutics Corp、Maze Therapeutics, Inc.，振幅分别为19.20%、14.67%、8.87%。Lixte Biotechnology Holdings, Inc.公司简介：Lixte Biotechnology Holdings Inc 是一家生物制药公司，致力于通过开发一种名为蛋白磷酸酶 2A 抑制剂的药物来改善患者的生活。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250225223207abdc7e0b&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250225223207abdc7e0b&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LIXT","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2514577713","title":"Lixte Biotechnology Holdings, Inc.盘中异动 下午盘股价大涨5.50%报1.34美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2514577713","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2514577713?lang=zh_cn&edition=full","pubTime":"2025-02-25 02:59","pubTimestamp":1740423550,"startTime":"0","endTime":"0","summary":"北京时间2025年02月25日02时59分，Lixte Biotechnology Holdings, Inc.股票出现波动，股价大幅上涨5.50%。Lixte Biotechnology Holdings, Inc.股票所在的生物技术行业中，整体跌幅为0.29%。其相关个股中，Nutriband Inc C/Wts 、Pepgen Inc.、Surrozen Inc C/Wts 01/08/2031 涨幅较大，Pepgen Inc.、Aditxt, Inc.、Allarity Therapeutics, Inc.较为活跃，换手率分别为319.51%、134.95%、39.32%，振幅较大的相关个股有Nutriband Inc C/Wts 、Pepgen Inc.、Surrozen Inc C/Wts 01/08/2031 ，振幅分别为176.22%、162.04%、81.92%。Lixte Biotechnology Holdings, Inc.公司简介：Lixte Biotechnology Holdings Inc 是一家生物制药公司，致力于通过开发一种名为蛋白磷酸酶 2A 抑制剂的药物来改善患者的生活。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025022502591098912c04&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025022502591098912c04&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LIXT","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2513292625","title":"Lixte Biotechnology Holdings, Inc.盘中异动 早盘股价大跌5.15%","url":"https://stock-news.laohu8.com/highlight/detail?id=2513292625","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2513292625?lang=zh_cn&edition=full","pubTime":"2025-02-21 23:49","pubTimestamp":1740152974,"startTime":"0","endTime":"0","summary":"北京时间2025年02月21日23时49分，Lixte Biotechnology Holdings, Inc.股票出现波动，股价急速下跌5.15%。Lixte Biotechnology Holdings, Inc.股票所在的生物技术行业中，整体涨幅为0.05%。其相关个股中，Osr Holdings, Inc.、Osr Holdings Inc C/Wts 09/02/2028 、Nkgen Biotech, Inc.涨幅较大，Nkgen Biotech, Inc.、Aditxt, Inc.、Osr Holdings, Inc.较为活跃，换手率分别为182.75%、126.54%、113.64%，振幅较大的相关个股有Osr Holdings, Inc.、Osr Holdings Inc C/Wts 09/02/2028 、Nkgen Biotech, Inc.，振幅分别为67.41%、57.50%、48.19%。Lixte Biotechnology Holdings, Inc.公司简介：Lixte Biotechnology Holdings Inc 是一家生物制药公司，致力于通过开发一种名为蛋白磷酸酶 2A 抑制剂的药物来改善患者的生活。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250221234934962b8cf5&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250221234934962b8cf5&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LIXT","BK4139"],"isVideo":false,"video":null,"gpt_icon":0}],"profile":{"websiteUrl":"http://www.lixte.com","stockEarnings":[{"period":"1week","weight":-0.0552},{"period":"1month","weight":0.1199},{"period":"3month","weight":1.3269},{"period":"6month","weight":0.7666},{"period":"1year","weight":8.3377},{"period":"ytd","weight":0.8295}],"compareEarnings":[{"period":"1week","weight":-0.0238},{"period":"1month","weight":-0.0286},{"period":"3month","weight":0.1497},{"period":"6month","weight":0.056},{"period":"1year","weight":0.1914},{"period":"ytd","weight":0.069}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"Lixte Biotechnology Holdings, Inc.于2005年5月24日以特拉华州公司的名义注册成立，名称为SRKP 7，Inc。2006年12月7日，公司更名为Lixte Biotechnology Holdings，Inc.。该公司是一家药物发现公司。使用生物标记技术来识别与严重常见疾病相关的酶靶标，然后设计新颖的化合物来攻击那些靶标。该公司的产品线主要专注于蛋白质磷酸酶抑制剂，可单独使用或与细胞毒性剂和X射线和免疫检查点阻滞剂组合使用，涵盖临床前和临床开发各个阶段的两大类化合物。","yearOnYearQuotes":[{"month":1,"riseRate":0.5,"avgChangeRate":0.153774},{"month":2,"riseRate":0.625,"avgChangeRate":0.06495},{"month":3,"riseRate":0.5,"avgChangeRate":-0.03366},{"month":4,"riseRate":0.375,"avgChangeRate":-0.074412},{"month":5,"riseRate":0.444444,"avgChangeRate":0.082784},{"month":6,"riseRate":0.555556,"avgChangeRate":0.044413},{"month":7,"riseRate":0.625,"avgChangeRate":0.400968},{"month":8,"riseRate":0.5,"avgChangeRate":0.097631},{"month":9,"riseRate":0.375,"avgChangeRate":0.00973},{"month":10,"riseRate":0.375,"avgChangeRate":-0.019298},{"month":11,"riseRate":0.375,"avgChangeRate":-0.035386},{"month":12,"riseRate":0.25,"avgChangeRate":-0.145393}],"exchange":"NASDAQ","name":"Lixte Biotechnology Holdings Inc.","nameEN":"Lixte Biotechnology Holdings Inc."},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"isLaohu8Offline":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.44.0","shortVersion":"4.44.0","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Lixte Biotechnology Holdings Inc.(LIXT)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供Lixte Biotechnology Holdings Inc.(LIXT)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"Lixte Biotechnology Holdings Inc.,LIXT,Lixte Biotechnology Holdings Inc.股票,Lixte Biotechnology Holdings Inc.股票老虎,Lixte Biotechnology Holdings Inc.股票老虎国际,Lixte Biotechnology Holdings Inc.行情,Lixte Biotechnology Holdings Inc.股票行情,Lixte Biotechnology Holdings Inc.股价,Lixte Biotechnology Holdings Inc.股市,Lixte Biotechnology Holdings Inc.股票价格,Lixte Biotechnology Holdings Inc.股票交易,Lixte Biotechnology Holdings Inc.股票购买,Lixte Biotechnology Holdings Inc.股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Lixte Biotechnology Holdings Inc.(LIXT)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供Lixte Biotechnology Holdings Inc.(LIXT)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}